Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-17-000040
Filing Date
2017-05-09
Accepted
2017-05-09 17:19:40
Documents
93
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q valeantq12017.htm 10-Q 1891807
2 EXHIBIT 31.1 exhibit311q12017.htm EX-31.1 14540
3 EXHIBIT 31.2 exhibit312q12017.htm EX-31.2 14575
4 EXHIBIT 32.1 exhibit321q12017.htm EX-32.1 8730
5 EXHIBIT 32.2 exhibit322q12017.htm EX-32.2 8719
  Complete submission text file 0000885590-17-000040.txt   10007008

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vrx-20170331.xml EX-101.INS 2134908
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrx-20170331.xsd EX-101.SCH 75382
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrx-20170331_cal.xml EX-101.CAL 139103
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrx-20170331_lab.xml EX-101.LAB 908525
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrx-20170331_pre.xml EX-101.PRE 568500
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrx-20170331_def.xml EX-101.DEF 385630
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 17827556
SIC: 2834 Pharmaceutical Preparations